investig
mass
spectra
previous
measur
sampl
includ
digest
protein
commerci
avail
protein
plu
two
human
integrin
measur
first
prepar
mgml
solut
follow
commerci
avail
protein
mm
ammonium
bicarbon
human
bovin
carbon
anhydras
rabbit
phosphorylas
b
bovin
catalas
bovin
porcin
pepsinogen
rabbit
dehydrogenas
hors
heart
cytochrom
c
hors
heart
myoglobin
bovin
chymotrypsinogen
bovin
serum
albumin
bovin
human
serum
albumin
bovin
bovin
ribonucleas
human
integrin
human
protein
reduc
mm
dtt
min
alkyl
mm
iodoacetamid
min
dark
room
temperatur
dialyz
mm
h
da
mwco
pierc
digest
overnight
sequenc
grade
trypsin
promega
enzymesubstr
ratio
h
human
sampl
process
without
f
pngase
f
roch
molecular
biochem
deglycosyl
integrin
perform
dialysi
trypsin
step
pngase
f
overnight
sar
viru
nucleocapsid
digest
accord
procedur
describ
shevchenko
et
digest
mix
maldi
matrix
solut
mgml
dihydroxybenzo
acid
wateracetonitril
deposit
gold
surfac
maldi
target
subject
analysi
addit
previous
record
ms
msm
spectra
sampl
also
made
new
measur
model
peptid
sigma
also
examin
geoghegan
et
al
studi
access
amino
group
chemic
modif
without
cycliz
peptid
mgml
mm
alkyl
mm
iodoacetamid
min
room
temperatur
dark
store
h
result
product
treat
caf
reagent
kit
chemic
assist
fragment
amersham
bioscienc
accord
manufactur
instruct
order
modifi
group
contain
mass
spectrometri
great
power
discrimin
complex
biolog
sampl
mixtur
protein
digest
describ
still
present
challeng
hplc
separ
often
help
allevi
problem
sinc
separ
hplc
fraction
like
much
simpler
mass
spectra
origin
sampl
case
also
essenti
show
modif
observ
took
place
prior
entri
mass
spectromet
sinc
da
loss
commonli
observ
ioniz
howev
optimum
condit
oper
hplc
system
mass
spectromet
usual
differ
time
scale
two
process
coupl
hplc
system
mass
spectromet
commonli
use
esi
may
requir
undesir
compromis
contrast
simplest
mode
coupl
hplc
maldi
system
advantag
complet
decoupl
two
techniqu
enabl
separ
optim
remov
time
constraint
mass
spectrometr
coupl
also
allow
ms
msm
measur
make
possibl
sampl
long
initi
measur
complet
mixtur
protein
digest
prepar
appropri
dilut
trifluoroacet
acid
tfa
aqueou
solut
pmol
inject
hplc
system
chromatograph
separ
perform
use
seri
system
agil
technolog
wilmington
de
usa
deioniz
water
acetonitril
use
prepar
eluent
sampl
inject
onto
mm
column
vydac
tp
grace
vydac
hesperia
ca
usa
elut
linear
gradient
acetonitril
tfa
min
column
effluent
mix
dihydroxybenzo
acid
matrix
solut
deposit
robot
onto
movabl
gold
target
fraction
collect
sinc
almost
tryptic
peptid
elut
min
chromatograph
condit
use
extract
contain
peptid
mixtur
digest
sar
viru
nucleocapsid
protein
lyophil
tfa
use
direct
analysi
rest
analyz
describ
fraction
cdpgyigsr
model
peptid
reaction
mixtur
perform
use
mm
column
vydac
tp
flow
rate
inject
loop
linear
gradient
acetonitril
tfa
min
absorb
column
effluent
monitor
nm
fraction
correspond
two
main
peak
chromatogram
collect
lyophil
tfa
deposit
target
analysi
msm
peptid
mass
fingerprint
individu
digest
confirm
ident
protein
chromatograph
fraction
analyz
singl
mass
spectrometri
ms
mz
rang
tandem
mass
spectrometri
msm
manitobasciex
prototyp
quadrupoletof
qqtof
mass
spectromet
commerci
model
sold
qstar
appli
biosystemsmd
sciex
foster
citi
ca
usa
instrument
ion
produc
irradi
sampl
photon
puls
hz
nitrogen
laser
vcl
mountain
view
ca
usa
mj
energi
per
puls
orthogon
inject
ion
quadrupol
tof
section
normal
produc
mass
resolv
power
fwhm
accuraci
within
mda
tof
spectra
ms
msm
mode
mz
sn
ratio
profound
program
manitoba
centr
use
peak
assign
peptid
mass
fingerprint
analysi
respect
mention
two
glycosyl
peptid
sugar
composit
found
consecut
fraction
analysi
human
integrin
digest
shown
fig
b
msm
analysi
label
peak
shown
allow
us
determin
mass
peptid
part
separ
speci
da
mh
b
respect
first
one
correspond
tryptic
fragment
human
integrin
cheg
n
gtfecgacr
calcul
mass
da
da
mass
shift
one
elut
later
fig
excel
agreement
loss
ammonia
calcul
mass
da
predict
cycliz
reaction
illustr
scheme
b
see
tabl
b
note
fraction
provid
complet
separ
two
speci
show
loss
occur
prior
ms
recent
studi
sar
viru
associ
protein
includ
de
novo
sequenc
kda
nucleocapsid
two
tryptic
fragment
carri
gln
residu
sequenc
along
degrad
product
contain
pyroglutam
acid
residu
tabl
figur
c
e
show
detect
qynvtqafgr
peptid
sar
viru
nucleocapsid
protein
da
deriv
use
chromatograph
fraction
prior
analysi
also
yield
least
increas
detect
sensit
fig
c
e
resolv
peak
close
mz
valu
also
separ
peptid
similar
chemic
structur
even
import
case
da
product
elut
later
sar
nucleocapsid
peptid
investig
question
data
digest
protein
previous
obtain
purpos
calibr
system
calcul
known
sequenc
show
mixtur
theoret
contain
uniqu
tryptic
peptid
cy
residu
within
mass
rang
da
direct
measur
individu
digest
follow
automat
peak
assign
use
mz
program
abl
identifi
profound
mass
fingerprint
one
digest
mixtur
examin
contrast
analysi
hplcm
data
digest
mixtur
sn
ratio
allow
reveal
peptid
emphas
consider
improv
provid
hplc
separ
manual
examin
spectra
show
eight
peptid
identifi
program
poor
sn
ratio
previous
record
ms
msm
spectra
identifi
peptid
cy
residu
along
spectra
six
peptid
gln
residu
comparison
tabl
data
tabl
includ
mz
valu
peptid
mass
differ
origin
peptid
product
degre
convers
direct
individu
digest
distribut
chromatograph
fraction
degre
convers
calcul
base
ratio
monoisotop
peak
area
ie
area
product
area
product
area
origin
peptid
assum
chemic
transform
chang
maldi
respons
paramet
estim
data
ms
signal
differ
fraction
could
affect
peptid
due
suppress
effect
da
product
elut
later
peptid
studi
except
two
hydrophil
fragment
bovin
serum
albumin
qeper
human
integrin
cnegr
exampl
separ
bovin
cevfr
fragment
present
fig
f
g
h
averag
mass
shift
calcul
data
tabl
da
gln
cy
respect
good
agreement
calcul
valu
elimin
da
msm
measur
also
confirm
loss
da
carboxamidomethyl
cy
intern
cystein
msm
spectrum
da
fragment
fig
f
exhibit
complet
seri
b
product
ion
except
tabl
averag
degre
degrad
found
gln
cy
respect
tabl
differ
indic
somewhat
favor
format
ring
one
monitor
time
cours
reaction
bovin
serum
albumin
porcin
pepsinogen
mgml
subject
digest
h
degrad
ccteslvnr
qyytvfdr
peptid
monitor
fig
accord
data
tabl
fig
typic
overnight
digest
h
case
result
transform
peptid
cy
residu
alkyl
iodoacetamid
reason
agreement
h
obtain
cgygpkkkrkvgg
cdpgyigsr
geoghegan
et
studi
access
amino
group
subject
mixtur
cdpgyigsr
peptid
alkyl
iodoacetamid
da
deriv
modif
caf
procedur
involv
coupl
acid
peptid
result
product
expect
exhibit
da
calcul
mass
shift
prefer
format
seri
product
ion
msm
figur
show
ms
spectra
peptid
solut
min
alkyl
room
temperatur
fig
storag
reaction
mixtur
overnight
fig
b
treatment
caf
reagent
fig
c
overnight
storag
reaction
solut
result
transform
da
peptid
da
product
fig
b
transform
confirm
hplc
fraction
reaction
mixtur
fig
b
two
promin
peak
observ
chromatogram
separ
min
correspond
unmodifi
da
peptid
da
product
fig
ident
peptid
confirm
base
ratio
peak
area
fig
calcul
degre
convers
compar
fig
b
subsequ
modif
caf
reagent
show
appear
da
modifi
product
da
fragment
da
mass
differ
wherea
da
peptid
contain
acid
appear
intact
fig
c
exampl
provid
addit
proof
cycliz
carboxamidomethyl
cy
also
make
possibl
estim
decreas
sensit
caus
coupl
strongli
acid
group
peak
intens
da
peptid
found
time
less
expect
ratio
peak
intens
da
fragment
coupl
hplc
mass
spectrometr
measur
provid
use
method
distinguish
da
loss
describ
similar
loss
occur
mass
spectromet
modifi
da
fragment
alway
elut
differ
time
usual
later
column
unmodifi
counterpart
gln
cy
differ
retent
time
found
min
short
gradient
indic
signific
influenc
chemistri
chromatograph
behavior
peptid
cycliz
carboxamidomethyl
cy
acid
residu
observ
identifi
tryptic
peptid
cy
suggest
reaction
alway
take
place
sampl
prepar
iodoacetamid
use
alkyl
agent
reaction
could
avoid
use
iodoacet
acid
reagent
found
less
desir
purpos
least
hand
neglect
reaction
lead
signific
decreas
detect
sensit
peptid
mass
spectrometri
typic
overnight
digest
howev
characterist
presenc
two
fragment
differ
mass
da
appear
differ
chromatograph
fraction
may
fact
aid
identif
cystein
long
mass
spectrometrist
program
fulli
awar
possibl
